Sartorius Stedim Biotech: Update on share capital and voting rights

Sartorius Stedim Biotech SA has published a regulatory statement concerning its share capital and associated voting rights. As of October 31, 2026, the total number of shares comprising the company's share capital was 97,330,405. The total number of theoretical voting rights, including those relating to treasury shares, was 164,924,442. The net voting rights, excluding treasury shares, were 164,903,992. This update, in accordance with Article L 233-8-II of the French Commercial Code and Article 223-6 of the AMF General Regulation, provides shareholders and the market with greater transparency regarding the governance structure of Sartorius Stedim Biotech SA.